Synbio Technologies Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 70
Employees
  • Latest Deal Type
  • IPO
  • Investors
  • 1

Synbio Technologies General Information

Description

Developer of DNA synthesis technology for the bio-tech field. The company's platform consist of Syno 1.0, Syno 2.0 and Syno 3.0 that construct a humanized antibody library, optimize industrial enzymes, chromosome/genome synthesis, develop genetic engineering vaccines and DNA informatics storage technology. The company also developed an advanced biotechnology transformation and application platform that follows the biological central dogma, and expands genotype, phenotype and synotype effectively, providing their customers with an one stop solution of gene design-construction-application.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Building C20, Bio-Nano Park
  • 218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 400 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synbio Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. IPO 07-Nov-2017 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 14-Jul-2016 00.000 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 19-Sep-2014 $1.63M $1.63M Completed Startup
To view Synbio Technologies’s complete valuation and funding history, request access »

Synbio Technologies Executive Team (1)

Name Title Board Seat Contact Info
Ping Yang Chief Executive Officer, Chairman & Founder
To view Synbio Technologies’s complete executive team members history, request access »

Synbio Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synbio Technologies Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BGI Corporation Minority 000 0000 000000 0
To view Synbio Technologies’s complete investors history, request access »